A detailed history of Wells Fargo & Company transactions in Omeros Corp stock. As of the latest transaction made, Wells Fargo & Company holds 27,897 shares of OMER stock, worth $168,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,897
Previous 27,403 1.8%
Holding current value
$168,218
Previous $111,000 0.9%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.54 - $5.47 $1,748 - $2,702
494 Added 1.8%
27,897 $110,000
Q2 2024

Aug 13, 2024

BUY
$3.04 - $4.23 $11,001 - $15,308
3,619 Added 15.22%
27,403 $111,000
Q1 2024

May 10, 2024

BUY
$2.88 - $4.89 $7,574 - $12,860
2,630 Added 12.43%
23,784 $82,000
Q4 2023

Feb 09, 2024

BUY
$1.08 - $3.63 $3,949 - $13,274
3,657 Added 20.9%
21,154 $69,000
Q3 2023

Nov 13, 2023

SELL
$2.81 - $5.69 $28,701 - $58,117
-10,214 Reduced 36.86%
17,497 $51,000
Q2 2023

Aug 15, 2023

BUY
$4.45 - $7.57 $105,362 - $179,234
23,677 Added 586.94%
27,711 $150,000
Q1 2023

May 12, 2023

SELL
$2.48 - $5.22 $726 - $1,529
-293 Reduced 6.77%
4,034 $18,000
Q4 2022

Feb 13, 2023

SELL
$1.75 - $3.96 $6,457 - $14,612
-3,690 Reduced 46.03%
4,327 $9,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $6,498 - $15,688
-2,103 Reduced 20.78%
8,017 $24,000
Q2 2022

Aug 12, 2022

SELL
$1.92 - $6.28 $13,921 - $45,536
-7,251 Reduced 41.74%
10,120 $27,000
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $105,004 - $149,119
-20,711 Reduced 54.39%
17,371 $105,000
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $86,189 - $129,816
15,201 Added 66.44%
38,082 $244,000
Q3 2021

Nov 15, 2021

SELL
$13.4 - $16.3 $157,945 - $192,128
-11,787 Reduced 34.0%
22,881 $316,000
Q2 2021

Aug 16, 2021

SELL
$14.81 - $19.13 $53,982 - $69,728
-3,645 Reduced 9.51%
34,668 $515,000
Q1 2021

May 13, 2021

SELL
$14.52 - $23.53 $1.24 Million - $2.01 Million
-85,401 Reduced 69.03%
38,313 $682,000
Q4 2020

Feb 09, 2021

BUY
$10.14 - $15.19 $165,515 - $247,946
16,323 Added 15.2%
123,714 $1.77 Million
Q3 2020

Nov 05, 2020

SELL
$9.57 - $21.32 $102,092 - $227,441
-10,668 Reduced 9.04%
107,391 $1.09 Million
Q2 2020

Aug 13, 2020

BUY
$12.21 - $16.99 $159,169 - $221,481
13,036 Added 12.41%
118,059 $1.74 Million
Q1 2020

May 14, 2020

BUY
$9.03 - $19.72 $948,357 - $2.07 Million
105,023 New
105,023 $1.4 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $378M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.